Skip to main content
PAS 2024 Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Pre-Conference Ticketed Event
Pre-Conference Ticketed Event
APA Award Winner
APA Award Winner
APS Award Winner
APS Award Winner
ASPN Award Winner
ASPN Award Winner
SPR Award Winner
SPR Award Winner
On Demand Presentation
On Demand Presentation
Poster Icons
SPR Award Winner
SPR Award Winner
Back
Evaluation ViewAttendees 177
Hot Topic Symposia

Cardiology

Critical Care

Hematology/Oncology

Neonatology

Quality Improvement/Patient Safety

Trainee
Session Type: Hot Topic Symposia

Advances in Neonatal Transfusion: New Insights on WHEN and WHAT We Should Transfuse

Saturday, May 4, 2024
11:00 AM – 12:30 PM ET
Location: Metro Toronto Convention Centre: 107
CE: Live CME: 1.5

Selected By: Neonatal
Disclosure(s):
Ravi M. Patel, MD, MSc: Infant Bacterial Therapeutics / Premier Research (Ongoing) (Products/Services: Consultant); Noveome (Ongoing) (Products/Services: Consultant)
Martha Sola-Visner, MD: Johnson & Johnson (Ongoing) (Products/Services: Consultant); Sysmex America, Inc. (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator)

Session

Description: What an exciting time in neonatal transfusion medicine. This symposium will discuss recent advances in the field, starting with WHEN we should transfuse both red blood cells and platelet into preterm infants. We will review the latest evidence from the TOP, ETTNO and PlaNeT-2 randomized trials. Next, we will discuss WHAT we should be transfusing, increasing the audience’s knowledge of the potential impact of the blood products and donors used for neonatal transfusion by highlighting cutting-edge research in the field. We will finish with how patient blood management can be used to translate evidence to the bedside. The session will conclude with a robust discussion about the current state of evidence in neonatal transfusion and gaps that need to be addressed.

Learning Objectives:

  • Describe evidence from clinical trials of thresholds for red blood cell and platelet transfusion in preterm infants.
  • Understand how blood banking practices and donor characteristics may impact the effectiveness and safety of blood transfusion.
  • Identify key patient blood management strategies to translate evidence into routine care.

Presentations:

  • 11:00 AM – 11:15 AM ET
    Why Studying Blood Donors is Important for Neonatal Transfusion

    Speaker: Ravi M. Patel, MD, MSc (he/him/his) – Emory University & Children's Healthcare of Atlanta

  • 11:15 AM – 11:30 AM ET
    Advances and Controversies in Neonatal Blood Banking Practices

    Speaker: Cassandra Josephson, MD – Johns Hopkins University School of Medicine

  • 11:30 AM – 11:45 AM ET
    Threshold Trials of Red Blood Cells: Considerations for Practice

    Speaker: Haresh Kirpalani, BM, MSc – Children's Hospital of Philadelphia

  • 11:45 AM – 12:00 PM ET
    Threshold Trials of Platelets: Why Less is More

    Speaker: Martha Sola-Visner, MD (she/her/hers) – Boston Children's Hospital

  • 12:00 PM – 12:15 PM ET
    Patient Blood Management and Platelet Transfusions

    Speaker: Patricia Davenport, MD (she/her/hers) – Boston Children's Hospital